Lessons in Laboratory Compliance from a $30 Million Settlement
‘Lean lab’ setup appears to have caught the eyes of investigators
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
‘Lean lab’ setup appears to have caught the eyes of investigators
The proposal seeks to move any future LDT authority away from the FDA
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence
Deal could prove a boost to the company, which has struggled since 2023
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices
Hologic has been on the vanguard of developing and distributing tests focusing on women’s health
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams
Biotech giant purchased the company for $21 billion, one of the largest deals in clinical lab history
In both cases, the diagnostic tests report results back within 15 minutes